WOONSOCKET, R.I., Jan. 18, 2013 /PRNewswire/ -- CVS Caremark (NYSE: CVS) is working to resolve service issues related to its SilverScript Medicare Part D Prescription Drug Plan. Issues with SilverScript enrollment processing resulted from an enrollment system conversion and brought about an increase in call volume and issues related to claims processing, including, in some instances, not being able to have claims adjudicated at the pharmacy. As a consequence, the Centers for Medicare and Medicaid Services (CMS) has placed SilverScript on intermediate sanctions, effective as of 11:59PM EST January 15, 2013.
Enrollment of any Medicare beneficiaries in the SilverScript plan and all marketing activities have been suspended. The CMS action does not affect current SilverScript members and these beneficiaries will continue to have access to covered services. Existing employer group health plans are not affected by this action; CVS Caremark health plan clients are not affected by this action. The company estimates that the sanctions should not have a material impact on its 2013 earnings.
"We take these issues very seriously and are committed to working swiftly with CMS officials to address their areas of concern," said Jon Roberts, President of the pharmacy benefit management business of CVS Caremark. "We also want to commit to members who experienced enrollment issues that we will resolve these expeditiously."About CVS CaremarkCVS Caremark is dedicated to helping people on their path to better health as the largest integrated pharmacy company in the United States. Through the company's more than 7,400 CVS/pharmacy stores; its leading pharmacy benefit manager serving more than 60 million plan members; and its retail health clinic system, the largest in the nation with more than 600 MinuteClinic locations, it is a market leader in mail order, retail and specialty pharmacy, retail clinics, and Medicare Part D Prescription Drug Plans. As a pharmacy innovation company with an unmatched breadth of capabilities, CVS Caremark continually strives to improve health and lower costs by developing new approaches such as its unique Pharmacy Advisor program that helps people with chronic diseases such as diabetes obtain and stay on their medications. SOURCE CVS Caremark
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts